Loading organizations...
Loading organizations...
Hongsheng Capital: Venture capital firm investing in technology, consumer, and healthcare startups from seed to growth stages.
HongShan Capital is a leading venture capital firm based in Beijing, China, investing in technology, consumer, and healthcare sectors from seed to growth stages. The firm provides hands-on support to portfolio companies, helping them scale into significant businesses across China, Singapore, the United States, Indonesia, Vietnam, and India. With approximately $9 billion in capital available for deployment, HongShan operates as a hybrid fund, actively seeking deals outside China following its recent independence. Key partners include Neil Shen, Steven Ji, and Trency Gu, with Neil Shen consistently recognized on the Forbes Midas List. The firm, originally established as Sequoia Capital China, rebranded to HongShan in June 2023 under the leadership of its founding and managing partner, Neil Shen, after Sequoia Capital's global split. It was founded in 2005.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 25, 2025 | Arnatar Therapeutics | $52.0M Series A | 3E Bioventures Capital, Eight Roads Ventures | Chuanhua Capital, F-Prime Capital, Gaorong Capital, New Alliance Capital, Yijing Capital |